Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Biodesix, Inc, a leading diagnostics solutions company, and Bio-Rad Laboratories, a global leader in life science research and diagnostics products, contributed to new research findings from Friends of Cancer Research's…

Continue ReadingBiodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

WHO launches new guidelines to tackle adolescent pregnancy and related health complications

In a bid to tackle the leading cause of death globally among 15–19-year-old girls, the World Health Organization (WHO) today released a new guideline aimed at preventing adolescent pregnancy and…

Continue ReadingWHO launches new guidelines to tackle adolescent pregnancy and related health complications

Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 kg with haemophilia…

Continue ReadingMarstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with haemophilia A or B